Australia's Bioxyne hits nearly 8-year high on cannabis firm deal
** Bioxyne BXN.AX rises as much as 9.5% to A$0.069, highest since June 5, 2018 ** Pharmaceutical firm says its unit entered into manufacturing deal with Canada-based Aurora Cannabis ACB.TO ** Adds deal covers supply of medicinal cannabis oils into Australian market ** YTD, BXN up more than 60% (Reporting by Rajasik Mukherjee in Bengaluru) ((Rajasik.Mukherjee@thomsonreuters.com))
Recent news on Bioxyne
See all newsBrief: Bioxyne Secures A$50M Exclusive German Supply Agreement With Adrex
Australia's Bioxyne rises to near 8-year high after company secures German supply deal
Australia's Bioxyne at two-week high on supply deal with Remidose LATAM
Brief: Bioxyne Expands LATAM Footprint First Supply Agreement Costa Rica
Australia's Bioxyne hits nearly 8-year high on cannabis firm deal